Revolutionizing Clinical Trials: AnzuBridge Unveils Next-Generation Solutions for Improved Efficacy Evaluations in the Treatment of Rare Disease
Summary
Phoenix, AZ, April 30, 2024 --( PR.com )-- AnzuBridge® is excited to introduce the latest enhancements to their Clinical Data Management System (CDMS), specifically designed to meet the unique video demands of biotech to evaluate efficacy milestones after post-therapeutic intervention. Additional features include secure transmission of data packets and storage in a HIPAA-compliant AWS cloud.Scalability and Flexibility: The system is designed to accommodate growing data volumes, and supports multi-center trials.Patient Engagement and Compliance: Many protocols require caregivers to record events during visit windows. The ePRO applications (IOS and Android) are designed to minimize the procedural and technical requirements for the patient and their caregivers. Additionally, users can instantly access specific points within training videos through Anzu’s patented video bookmarking technology.Potential AI integration: The precise placement of virtual pointers associated with clinical endpoints allows future integration of comparative AI analysis of the efficacy milestones. See firsthand how their integrated solutions can streamline your clinical trials, enhance data integrity, and accelerate therapy approval.About AnzuBridgeAnzuBridge revolutionizes clinical trials with advanced video capture and review technology tailored for the dynamic needs of modern medical research.